SHASUNPHAR

Shasun Pharmaceuticals Limited has informed the Exchange that there was a fire accident at New production block during trial & commissioning in Cuddalore API facility on November 16, 2015. Company regrets to inform the sad demise of one worker in the accident. One more injured employee has been admitted in the hospital for treatment. The Company has informed the government authorities about the same and investigating the root cause of the accident.The damage on account of fire is being assessed for which the company has adequate insurance cover. However there will not be any significant loss o

Shasun Pharmaceuticals Limited has informed the Exchange that the Company had completed the sale of 74,00,000 equity shares held in M/s. Alivira Animal Health Limited to M/s Sequent Scientific Limited.

Shasun Pharmaceuticals Limited has informed the Exchange that the Company has fixed January 30, 2015 as the cut-off date, for the purpose of ascertaining the list of Members eligible to vote on the proposed Extraordinary General Meeting of the Company.

Shasun Pharmaceuticals Limited has informed the Exchange that the Company has fixed January 30, 2015 as the cut-off date, for the purpose of ascertaining the list of Members eligible to vote on the proposed postal ballot for the purpose of Amalgamation.

Shasun Pharmaceuticals Limited has informed the Exchange that there was a fire accident at Ibuprofen IP Grade packing section in API facility at Pondicherry around 2.30 a.m. on April 27, 2014. This is an isolated packing section from the main production block and other grades packing section. There was no impact to the other manufacturing operations, product supplies and no major damage to the facility. There has not been human casualty or injuries. The facility is fully covered with insurance.

Shasun Pharmaceuticals Limited has informed the Exchange vide letter dated April 16, 2014 regarding "Update on Joint Venture- Alvira Animal Health Limited".

Shasun Pharmaceuticals Limited has informed the Exchange regarding Joint venture agreement with Sequent Scientific Limited.

Shasun Pharmaceuticals Limited has informed the Exchange vide letter dated March 07, 2014, titled"Joint Venture Agreement".

Shasun Pharmaceuticals Limited has informed the Exchange, vide letter dated June 28, 2013 that "An amicable settlement has been reached with the workers at the Company's Pondicherry facility. The strike has been called off and operations resumed from yesterday night".

Shasun Pharmaceuticals Limited has informed the Exchange that an illegal strike was resorted by the workers at the Company's Pondicherry facility (API and Formulation) on June 15, 2013. The Company is doing needful to resume the operations at the earliest.

Shasun Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on March 21, 2013 has approved the conversion of 15,00,000 convertible warrants into equity shares of the Company, which were issued to the promoters and directors on preferential basis at a price of Rs. 75 per share including premium of Rs. 73 per share after obtaining the in-principle approvals from the stock exchanges.

Shasun Pharmaceuticals Limited has submitted to the Exchange a copy of letter from the Company's Managing Director dated January 29, 2013 to be sent to the Company's Shareholders.

Shasun Pharmaceuticals Limited has submitted to the Exchange a copy of letter from the Company's Managing Director dated February 21, 2012 to be sent to the Company's Shareholders.

Shasun Pharmaceuticals Limited has informed the Exchange that the operations has resumed at the Company's Cuddalore plant on January 05, 2012.

Shasun Pharmaceuticals Limited has informed the Exchange that the operations at Cuddalore plant of the Company has been interrupted due to severe cyclonic storm "Thane" on December 30, 2011, resulting in temporary suspension of the operations. The Company is doing needful to resume the operations at the earliest.

Shasun Pharmaceuticals Limited has submitted to the Exchange a copy of letter from Company's Managing Director dated November 05, 2011 to be sent to the Company's Shareholders.

Shasun Pharmaceuticals Limited has informed the Exchange that an amicable settlement has been reached with the workers at the Company's Pondicherry API Unit. The strike has been called off and operations resumed from May 25, 2011.

Shasun Pharmaceuticals Limited has informed the Exchange that "An illegal strike was resorted by the workers at our Pondicherry API Unit on 10th May 2011. The Company is doing needful to resume the operations at the earliest".

Shasun Pharmaceuticals Limited has informed the Exchange that the Company has been permitted to resume the operations at Cuddalore factory on April 22, 2011.

Shasun Pharmaceuticals Limited has informed the Exchange vide its letter dated April 22, 2011, that "The Company has been permitted to resume the operations at our Cuddalore factory today".

Shasun Pharmaceuticals Limited has informed the Exchange that there was chemical leak in the stores area at their Cuddalore factory on March 7, 2011 night which has been controlled. The production in the factory has been stopped on the direction of the government authorities. The Company is doing the needful to resume the operations at the earliest.

Shasun Pharmaceuticals Limited has informed the Exchange that Mr. Somnath Iyer, Chief Financial Officer has resigned from the services of the company. Mr. S. Hariharan will be the new Chief Financial Officer cum Compliance Officer of the company with immediate effect.

Shasun Chemicals And Drugs Ltd. has informed the Exchange vide its letter dated September 11, 2009 that "Tamil Nadu Pollution Control Board (TNPCB) has revoked its closure notice of the Cuddalore plant situated at SIPCOT Industrial complex in Cuddalore, Tamil Nadu. The Cuddalore unit is restarting its operations today".

Shasun Chemicals And Drugs Ltd. has informed the Exchange that: "The sale of Annan plant at Scotland belonging to our step-down subsidiary, Shasun Pharma Solutions Limited, which was closed in March 2009 has been successfully concluded. The plant has been sold to Phoenix Chemicals, Wirral, Cheshire, England".

Shasun Chemicals And Drugs Ltd. has informed the Exchange that "Company has received notice from Tamil Nadu Pollution Control Board under The Air (Prevention and Control of Pollution) Act, 1981 for closure of Plant situated at SIPCOT Industrial complex in Cuddalore, Tamil Nadu. Consequent to the notice, the operations at the Cuddalore plant have been stopped effective 25th August 2009. The closure will result in partial disruption to the Cuddalore operations. The Company has preferred an appeal and is confident of resolving the issue at the earliest".